Automated Screening for Clinically Ascertained Loss of Cerebral Functions

NANot yet recruitingINTERVENTIONAL
Enrollment

4,800

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

November 1, 2026

Study Completion Date

November 1, 2026

Conditions
Irreversible Loss of Brain Function (ILBF)
Interventions
OTHER

DETECT

DETECT periodically processes real-time data from the corresponding electronic medical record system to screen for a combination of coma, indicated by a Richmond Agitation Sedation Scale (RASS) score of - 4 or - 5 or Glasgow Coma Scale (GCS) score of 6-3, along with manually assessed absence of bilateral pupillary light reflexes. Both findings are considered early indicators of impending ILBF. In case of positive screening results, an automated notification will be sent via the hospital's email server to the corresponding transplant coordinators and intensivists. The email sent aims to prompt clinical assessment of the reported patient and, if necessary, initiate a guideline-based ILBF examination.

OTHER

Conventional care

Conventional care

Trial Locations (1)

01307

Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden

All Listed Sponsors
lead

Technische Universität Dresden

OTHER

NCT06293170 - Automated Screening for Clinically Ascertained Loss of Cerebral Functions | Biotech Hunter | Biotech Hunter